GlassScriptPhysician profile
Prasad Chappidi
NPI 1013032499
$8,148.32
in general payments reported to CMS, 2019-2025
46 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,702 · 2020: $1,023 · 2021: $1,579 · 2022: $1,307 · 2023: $884 · 2024: $710 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $955.44 | 2021-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $746.49 | 2019-2024 | Emgality, Reyvow, Kisunla |
| Biogen, INC. | $658.59 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Pfizer INC. | $577.85 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $534.47 | 2019-2021 | |
| Ucb, INC. | $418.74 | 2019-2025 | Briviact |
| Janssen Pharmaceuticals, INC | $350.62 | 2020-2023 | Ponvory |
| Genentech USA, INC. | $301.56 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Avanir Pharmaceuticals, INC. | $273.51 | 2019-2022 | |
| Lundbeck LLC | $251.01 | 2019-2025 | Rexulti, Vyepti |
| Upsher-Smith Laboratories LLC | $247.93 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $245.98 | 2019-2021 | |
| Allergan, INC. | $222.33 | 2019-2020 | |
| Mdd US Operations, LLC | $211.48 | 2020-2025 | Gocovri, Apokyn, Myobloc |
| Biohaven Pharmaceutical Holding Company LTD. | $169.00 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasad Chappidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.